Athersys Stock: Focus On Stroke (NASDAQ:ATHX)

Athersys has been focused on developing a viable treatment for stroke for nearly 20 years. Read more to find out if now a good time to buy ATHX stock.

Related Keywords

United States ,Ireland ,Japan ,Ohio ,Japanese ,Americans ,Gil Van Bokkelen ,Daniel Camardo ,Ivor Mccleod ,Ohio Tax Authority ,Nasdaq ,Athersys Inc ,Athersy Japanese ,Healios Treasure ,Stow Ohio ,Horizon Therapeutics ,Athersys Board ,